Results

Total Results: 898 records

Showing results for "types".

401. Evidence for the Reaffirmation of the USPSTF Recommendaiton on Screening for High Blood Pressure (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/KSYrhQuAswGjTww_4sDFGZ
     December 01, 2007 - Evidence for the Reaffirmation of the USPSTF Recommendaiton on Screening for High Blood Pressure Evidence for the Reaffirmation of the U.S. Preventive Services Task Force Recommendation on Screening for High Blood Pressure Tracy Wolff, MD, MPH, and Therese Miller, DrPH Background: High blood pressure is common, and …

402. Archived: Evidence Summary: Blood Pressure in Adults (Hypertension): Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary15/blood-pressure-in-adults-hypertension-screening-2007
     October 15, 2007 - Share to Facebook Share to X Share to WhatsApp Share to Email Print archived Evidence Summary Blood Pressure in Adults (Hypertension): Screening October 15, 2007 Recommendations made by the USPSTF are independent of the U.S. government. The…

403. Screening For Illicit Drug Use: Recommendation Statement (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/Qh7NQD6ZEynjyRso7L5-gS
     January 15, 2008 - Screening For Illicit Drug Use: Recommendation Statement 1 Screening for Illicit Drug Use U.S. Preventive Services Task Force Recommendation Statement • The U.S. Preventive Services Task Force (USPSTF) makes recommendations about preventive care services for patients without recognized signs or symptoms of…

404. Archived: Evidence Summary: Obesity in Children and Adolescents: Screening, July 2005 | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/obesity-in-children-and-adolescents-screening-2005
     July 12, 2005 - Figure 4 models the short-term (1 year) results from these types of studies when translated to BMI percentiles

405. Archived: Final Evidence Summary: Folic Acid to Prevent Neural Tube Defects: Preventive Medication | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary25/folic-acid-to-prevent-neural-tube-defects-preventive-medication-2009
     May 15, 2009 - Share to Facebook Share to X Share to WhatsApp Share to Email Print archived Final Evidence Summary Folic Acid to Prevent Neural Tube Defects: Preventive Medication May 15, 2009 Recommendations made by the USPSTF are independent of the …

406. Screening and Interventions for Childhood Overweight: A Systematic Review (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/6desD2XJCQKF8ZDPMS-NU_
     July 01, 2005 - Figure 4 models the short-term (1 year) results from these types of studies when translated to BMI percentiles

407. Final Recommendation Statement: Breast Cancer: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/RecommendationStatementFinal/breast-cancer-screening
     April 30, 2024 - Institute has information on breast cancer screening for health care professionals ( https://www.cancer.gov/types … /breast/hp/breast-screening-pdq ) and for patients ( https://www.cancer.gov/types/breast/patient/breast-screening-pdq … https://www.cancer.gov/types/breast/hp/breast-treatment-pdq 16.

408. Evidence Summary: Cervical Cancer: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/cervical-cancer-screening
     August 21, 2018 - be prevented with detection and treatment of precancerous cell changes caused primarily by high-risk types … recognized as a causative agent in more than 90% of cervical cancers. 3 Persistent infection with hrHPV types … Primary hrHPV Compared With Cytology Screening Across 4 trials with variable protocols and hrHPV test types … although these trials had distinctly different screening protocols, screening intervals, and hrHPV test types

409. Screening for Obesity in Children and Adolescents: Recommendation Statement (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/DMDPeSf_nEUM-HrVrX6c7U
     June 20, 2017 - These types of interventions were often delivered by multidisciplinary teams, including pediatri­ cians … Detection and Interventions” sec­ tion to describe the components of effective interventions and the types

410. Behavioral Counseling Interventions to Promote a Healthy Diet and Physical Activity for CVD Prevention in Adults Without Known CVD Risk Factors: USPSTF Recommendation Statement (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/HMSNGkJatRuN5VoVWfbuFL
     March 01, 2022 - separate recom- mendation for persons with known CVD risk.21 Comments re- quested clarification on which types … The USPSTF recognizes and clarified that mul- tiple types of professionals, both medical and nonmedical

411. Evidence Summary: Oral Health in Children and Adolescents Aged 5 to 17 Years: Screening and Preventive Interventions | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary/oral-health-children-adolescents-screening-preventive-interventions
     November 07, 2023 - sealant, and 3 trials (n = 905 participants) evaluated a glass ionomer sealant (2 trials evaluated both types

412. Behavioral and Pharmacotherapy Weight Loss Interventions to Prevent Obesity-Related Morbidity and Mortality in Adults: Updated Evidence Report and Systematic Review for the USPSTF (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/boPWHmzrtxnkkPQAoCNENS
     September 18, 2018 - Behavioral and Pharmacotherapy Weight Loss Interventions to Prevent Obesity-Related Morbidity and Mortality in Adults: Updated Evidence Report and Systematic Review for the USPSTF Behavioral and Pharmacotherapy Weight Loss Interventions to Prevent Obesity-Related Morbidity and Mortality in Adults Updated Evidence Rep…

413. Final Research Plan: Lipid Disorders in Children and Adolescents: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan/lipid-disorders-in-children-screening
     August 19, 2021 - Share to Facebook Share to X Share to WhatsApp Share to Email Print Final Research Plan Lipid Disorders in Children and Adolescents: Screening August 19, 2021 Recommendations made by the USPSTF are independent of the U.S. government. They sh…

414. Final Research Plan: Autism Spectrum Disorder in Young Children: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan/autism-spectrum-disorder-young-children-1
     June 10, 2021 - Share to Facebook Share to X Share to WhatsApp Share to Email Print in progress Final Research Plan Autism Spectrum Disorder in Young Children: Screening June 10, 2021 Recommendations made by the USPSTF are independent of the U.S. govern…

415. Draft Research Plan: Autism Spectrum Disorder in Young Children: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/draft-research-plan/autism-spectrum-disorder-young-children-1
     February 25, 2021 - Share to Facebook Share to X Share to WhatsApp Share to Email Print in progress Draft Research Plan Autism Spectrum Disorder in Young Children: Screening February 25, 2021 Recommendations made by the USPSTF are independent of the U.S. govern…

416. Evidence Summary: Gestational Diabetes: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary/gestational-diabetes-screening
     August 10, 2021 - Share to Facebook Share to X Share to WhatsApp Share to Email Print Evidence Summary Gestational Diabetes: Screening August 10, 2021 Recommendations made by the USPSTF are independent of the U.S. government. They should not be construed as a…

417. Archived: Low-Dose Aspirin Use for the Prevention of Morbidity and Mortality From Preeclampsia: Preventive Medication | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/recommendation/low-dose-aspirin-use-for-the-prevention-of-morbidity-and-mortality-from-preeclampsia-preventive-medication-september-2014
     September 09, 2014 - Share to Facebook Share to X Share to WhatsApp Share to Email Print archived Final Recommendation Statement Low-Dose Aspirin Use for the Prevention of Morbidity and Mortality From Preeclampsia: Preventive Medication September 09, 2014 Re…

418. Health Equity Framework for the U.S. Preventive Services Task Force (pdf file)
     www.uspreventiveservicestaskforce.org/uspstf/sites/default/files/2023-12/health-equity-framework-report.pdf
     January 01, 2023 - The AF and other types of frameworks are sometimes collectively referred to as logic models or conceptual … best evidence may not be available and therefore may require more resources to answer than other types … preventive services for food insecurity) that have included such outcomes, the value of considering these types … stratified by study design with consideration of stratification of results by study risk of bias (i.e., types … because it is implied that a study need not be conducted).37 In general, guidelines should invoke these types

419. Evidence Summary: Weight Loss to Prevent Obesity-Related Morbidity and Mortality in Adults: Behavioral Interventions | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/obesity-in-adults-interventions
     September 18, 2018 - Share to Facebook Share to X Share to WhatsApp Share to Email Print Evidence Summary Weight Loss to Prevent Obesity-Related Morbidity and Mortality in Adults: Behavioral Interventions September 18, 2018 Recommendations made by the USPSTF are in…

420. Dwd2487Zxk6Uwpv2B4-Lqm (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/dWD2487zXk6uwpv2B4-LQM
     January 12, 2016 - U.S. Preventive Services Task Force Issues Final Recommendations on Screening for Breast Cancer Task Force confirms mammography is an important tool for women ages 40 to 74; recommends women ages 50 to 74 be screened regularly and women in their 40s make an individual decision in partnership with their doctors …